Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 
News | Cardiovascular Surgery
Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
Daxor’s Blood Volume (BVA-100) Diagnostic
News | Heart Failure
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure
February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data ...
Home February 18, 2022
Home
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
News | Endovascular Aortic Repair
Front Line Medical Technologies Expands Availability of its COBRA-OS

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...

Home February 18, 2022
Home
Already used in single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for adult patients, Rapiscan is now approved for use in stress cardiac magnetic resonance imaging (CMR)
News | Cardiac Imaging
GE Healthcare’s Stress Agent Rapiscan Approved for use in Stress Cardiac Magnetic Resonance Imaging

February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) ...

Home February 18, 2022
Home
Clinical Case of the Month
News | Cardiovascular Clinical Studies
Call for Entries!

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case ...

Home February 17, 2022
Home
Myocarditis (inflammation of the heart muscle) after vaccination is rare, but some cases have been reported after receipt of the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccine.
News | Coronavirus (COVID-19)
COVID Vax–related Myocarditis May be Milder Than That of Other Causes

February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as ...

Home February 17, 2022
Home
Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is leveraging its capabilities in the cardiology space with its new Cloud for Cardiology.
News | Cardiovascular Education
Mytonomy Announces Cardiology Content and Platform

February 17, 2022 – Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is ...

Home February 17, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Heart Failure | By Melinda Taschetta-Millane
Pig Heart Transplant Patient Continues to Thrive

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) ...

Home February 16, 2022
Home
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The BIOADAPTOR RCT is evaluating the DynamX Coronary Bioadaptor System,
News | Stents Drug Eluting
Elixir Medical Completes Enrollment in Bioadaptor Randomized Controlled Trial of DynamX Coronary Bioadaptor System

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced ...

Home February 16, 2022
Home
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand the presence of its Novasight Hybrid System in the U.S. market in 2022 under the guidance of its new leadership team.
News | Intra-Vascular Ultrasound (IVUS)
Conavi Medical Plans for Strategic Expansion in U.S. Market
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand ...
Home February 16, 2022
Home
Cardiology is an inherently data-dependent and data-driven practice. Patient medical history records, images, test results, and more go into every diagnosis and treatment decision.
News | Cardiovascular Information Systems (CVIS)
Structured Cardiology Reporting in CVIS Platforms Key to Better Patient Care, Outcomes

February 16, 2022 – Cardiology is an inherently data-dependent and data-driven practice. Patient medical history records ...

Home February 16, 2022
Home
Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus catheter-directed thrombolysis (CDT).
News | Pulmonary Embolism
Inari Medical Announces First Patient Enrolled in the PEERLESS Trial
February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a ...
Home February 16, 2022
Home
The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th pediatric heart transplant, a milestone that only a few centers across the country have reached.
News | Pediatric Cardiology
500th Heart Transplant Performed at Children’s Hospital Colorado
February 16, 2022 – The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th ...
Home February 16, 2022
Home
A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart arrhythmia diagnosis in clinical practice — has debuted at UC San Diego Health. vMap is a non-invasive, computational mapping system that produces a three-dimensional, interactive map of arrhythmia hotspots anywhere in the heart, including all four chambers of the organ, the septal wall and the outflow tracts.
News | Atrial Fibrillation
Remapping Atrial Fibrillation Treatment
February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart ...
Home February 16, 2022
Home
Amir Sheikhi, assistant professor of chemical engineering and biomedical engineering, Penn State. Image credit: Penn State College of Engineering
News | Stroke
Researchers Aim to Improve Stroke Recovery with New Granular Biomaterials
February 16, 2022 – The Centers for Disease Control and Prevention estimate that someone in the United States has a ...
Home February 16, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now